RETRACTED: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (Retracted article. See vol. 9, p. 1221, 2003)

被引:536
作者
Kugler, A
Stuhler, G
Walden, P
Zöller, G
Zobywalski, A
Brossart, P
Trefzer, U
Ullrich, S
Müller, CA
Becker, V
Gross, AJ
Hemmerlein, B
Kanz, L
Müller, GA
Ringert, RH
机构
[1] Univ Gottingen, Dept Nephrol & Rheumatol, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Urol, D-3400 Gottingen, Germany
[3] Univ Tubingen, Med Clin, Dept 2, Sect Transplantat Immunol & Immunohaematol, Tubingen, Germany
[4] Humboldt Univ, Charite, Dept Dermatol, Berlin, Germany
[5] Univ Gottingen, Dept Pathol, D-3400 Gottingen, Germany
关键词
D O I
10.1038/73193
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:332 / 336
页数:5
相关论文
共 16 条
[1]  
ANICHINI A, 1989, J IMMUNOL, V142, P3692
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J].
Brossart, P ;
Heinrich, KS ;
Stuhler, G ;
Behnke, L ;
Reichardt, VL ;
Stevanovic, S ;
Muhm, A ;
Rammensee, HG ;
Kanz, L ;
Brugger, W .
BLOOD, 1999, 93 (12) :4309-4317
[4]  
Brossart P, 1998, CANCER RES, V58, P732
[5]   Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients [J].
Fujita, K ;
Denda, K ;
Yamamoto, M ;
Matsumoto, T ;
Fujime, M ;
Irimura, T .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :301-308
[6]   Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells [J].
Gong, JL ;
Chen, DS ;
Kashiwaba, M ;
Kufe, D .
NATURE MEDICINE, 1997, 3 (05) :558-561
[7]   Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells [J].
Gong, JL ;
Chen, DS ;
Kashiwaba, M ;
Li, YQ ;
Chen, L ;
Takeuchi, H ;
Qu, H ;
Rowse, GJ ;
Gendler, SJ ;
Kufe, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6279-6283
[8]   EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS [J].
GUO, YJ ;
WU, MC ;
CHEN, H ;
WANG, XN ;
LIU, GL ;
LI, GL ;
MA, J ;
SY, MS .
SCIENCE, 1994, 263 (5146) :518-520
[9]  
Jantzer P, 1998, CANCER RES, V58, P3078
[10]   A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer [J].
Jayson, GC ;
Middleton, M ;
Lee, SM ;
Ashcroft, L ;
Thatcher, N .
BRITISH JOURNAL OF CANCER, 1998, 78 (03) :366-369